Drug dealing claims at an NYC Burger King have sparked a multi-million-dollar legal feud. Resident Kevin Kaufman alleges the franchisee allowed the restaurant to become an "open-air drug bazaar," leading to significant neighborhood distress and a sharp decline in property values.
NYC Resident Files $15 Million Lawsuit Against Burger King Franchisee Over Alleged Drug Dealing Operations
According to a $15 million lawsuit filed in the Manhattan Supreme Court (via Fox Business), a resident has filed suit against the franchisee of a Burger King location at 106 Fulton St., alleging that he allowed the establishment to become an "open-air drug bazaar" where drug dealing gangs use it "as a base of operation" to sell illegal drugs in and around the restaurant.
Kevin Kaufman, a resident, asserts that franchisee owner Lalmir Sultanzada permits illegal selling and has not employed security to deter criminal activity; as a result, the neighborhood attracts emotionally disturbed individuals who terrorize the locals and degrade their quality of life.
"These professional drug dealers, who have long criminal records and are well known among local law enforcement, operate in broad daylight from hours before the Burger King opens until hours after the Burger King closes, so openly that it is impossible for [Burger King and the franchise owner] to be unaware of this neighborhood nightmare," the March 5 suit stated.
"Fulton Street is now a neighborhood in crisis," the suit reads, with Kaufman claiming he has suffered "extreme emotional distress as a direct result of defendants' dangerous, illegal, unethical, and outrageous activity."
The lawsuit contends that the precipitous decline in the value of condominiums on Fulton Street is a direct consequence of Sultanzada's "reprehensible and morally reprehensible acceptance of illicit drug operations."
Because Sultanzada has turned a blind eye to the problem and refuses to employ private security, Kaufman, vice-chairman of the Fulton Street Coalition, a non-profit that "addresses the neighborhood's safety, welfare, and quality of life," asserts that neighbors are afraid to go outside at night.
NYC Mayor Visits Burger King Amid Drug Dealing Claims, Franchisee Files $30 Million Countersuit
The litigation even piqued the interest of Eric Adams, the mayor of New York City, who visited the restaurant in March, after the news article was published in the New York Post. According to Adams' office, the mayor did not meet with drug traffickers but rather homeless individuals inside the Burger King, where he allegedly "connected them to services."
It is approximately six blocks from Adams' office to the fast-food restaurant. However, Sultanzada responded to Kaufman in a $30 million countersuit filed last month, holding him accountable for the condition of the neighborhood because he is a member of a non-profit organization whose sole objective is to maintain the area's safety and quality of life.
The countersuit contends that Burger King's obligations "are limited to providing restaurant services to patrons and [it has] no obligation whatsoever to provide law enforcement services and/or ensure the safety, welfare, and quality of life of the neighborhood."
The countersuit also asserts that Kaufman is motivated by financial gain and that his characterization of the restaurant as an "open-air drug bazaar" that is "terrorizing his neighborhood" is racially charged, given that Sultanzada is an Afghan immigrant.
The countersuit also emphasizes an interview Kaufman conducted with the New York Post in which he attributes the city of New York's rampant drug trafficking to its criminal policies and laws.
"Defendants have absolutely no authority or control over such criminal laws and policies and the only possible action Burger King can take is to call the police, which it has done on many occasions," the countersuit reads.
Burger King did not respond to the comment request made by Fox Business before publication.
Photo: Microsoft Bing


NHS shakeup: if it sounds like we’ve been here before, it’s because we have
SpaceX Eyes AI Computing Expansion Ahead of Historic IPO
H.B. Fuller Eyes Advanced Medical Solutions in Potential £600M Takeover Deal
Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Texas Sues Meta Over WhatsApp Encryption Claims
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026
X Corp Loses Legal Battle Over Australia Child Safety Fine
Walmart Stock Falls Despite Strong Q1 Revenue Beat and E-Commerce Growth
Samsung Shares Surge After Strike Deal Eases Labor Tensions
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop 



